Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys - Zamarripa, C. Austin; Naylor, Jennifer E.; Huskinson, Sally L.; Townsend, E. Andrew; Prisinzano, Thomas E.; Freeman, Kevin B. (Psychopharmacology, 2020)
Keywords: Agonists; Analgesics; Analgesics, Opioid - administration & dosage; Animal experimentation; Animals; Behavior, Addictive - drug therapy; Behavior, Addictive - psychology; Biomedical and Life Sciences; Biomedicine; Central nervous system depressants; Cocaine; Cocaine - administration & dosage; Deterrents; Diterpenes, Clerodane - administration & dosage; Dose-Response Relationship, Drug; Drug self-administration; Experiments; Injection; Liability (Law); Macaca mulatta; Male; Morphinans - administration & dosage; Naltrexone - administration & dosage; Naltrexone - analogs & derivatives; Narcotic Antagonists - administration & dosage; Narcotics; Neurophysiology; Neurosciences; Opioid receptors (type kappa); Opioid receptors (type mu); Original Investigation; Oxycodone; Oxycodone - administration & dosage; Pharmacology/Toxicology; Psychiatry; Receptors, Opioid, kappa - agonists; Reinforcement, Psychology; Remifentanil; Salvinorin A; Self Administration; Spiro Compounds - administration & dosage; Punishment; Self-administration; Rhesus monkey; Oxycodone; Kappa opioid agonist